Non invasive assessment of airway inflammation by exhaled markers in EBC, sputum and NO

G. Becher, M. Rothe, C. Lehmann, R. Eichler (Berlin, Wuerzburg, Germany)

Source: Annual Congress 2004 - Biological markers in diagnosis, monitoring and treatment of respiratory disorders
Session: Biological markers in diagnosis, monitoring and treatment of respiratory disorders
Session type: Thematic Poster Session
Number: 3555
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Becher, M. Rothe, C. Lehmann, R. Eichler (Berlin, Wuerzburg, Germany). Non invasive assessment of airway inflammation by exhaled markers in EBC, sputum and NO. Eur Respir J 2004; 24: Suppl. 48, 3555

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Non invasive monitoring of airway inflammation in EBC and exhaled air is more sensitive than pulmonary function testing
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005

Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation
Source: Eur Respir J 2004; 24: 1011-1017
Year: 2004



Ozone-induced airway inflammation and its attenuation by corticosteroids are detectable in sputum samples but not in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 577s
Year: 2004

Noninvasive assessment of airway inflammation in asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164
Year: 2003

Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008


Exhaled breath condensate: is this yet of clinical value?
Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice
Year: 2005


Noninvasive estimation of inflammation and remodelling
Source: Annual Congress 2006 - PG4 - Asthma: pathology and treatment
Year: 2006



Noninvasive biomarkers of airway inflammation and oxidative stress in the exhaled breath of patients with bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 371s
Year: 2003

Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults
Source: Eur Respir J 2007; 30: 769-781
Year: 2007



Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 412s
Year: 2002

Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008


Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings
Source: Eur Respir J 2004; 24: Suppl. 48, 157s
Year: 2004

Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control
Source: Eur Respir J 2005; 26: Suppl. 49, 736s
Year: 2005

Oxidative stress evaluation in exhaled breath condensate (EBC) vs induced sputum (IS) in the assessment of lung diseases
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006